Breaking News

AbbVie to Build New API Manufacturing Facilities in North Chicago

Announces a $380 billion investment to support the production of AbbVie's next-gen neuroscience and obesity medications.

Author Image

By: Charlie Sternberg

Associate Editor

AbbVie is investing $380 million to build two new active pharmaceutical ingredient (API) manufacturing facilities at its current North Chicago, Illinois, campus. These new facilities will integrate advanced manufacturing technologies with artificial intelligence (AI) to support the production of AbbVie’s next-generation neuroscience and obesity medications. Construction will begin in spring 2026, with both new facilities expected to be fully operational in 2029. To support these new fac...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters